EDGAR ENGLEMAN, Director, Ten Percent Owner at Soleno Therapeutics, holds 2.07M shares in Bolt Biotherapeutics (Ticker: BOLT), holds 4.03M shares in Soleno Therapeutics (Ticker: SLNO), holds 1.60M shares in Eiger Biopharmaceuticals (Ticker: EIGRQ). Most recently, EDGAR ENGLEMAN Sold ― shares of Bolt Biotherapeutics on Dec 01, 2023 for an estimated value of 127.84K.
What is the percentage of profitable transactions made by EDGAR ENGLEMAN?
The percentage of profitable transactions made by EDGAR ENGLEMAN is 57%.
What is the average return per transaction made by EDGAR ENGLEMAN?
The average return per transaction made by EDGAR ENGLEMAN is -11.20%.
What stocks does EDGAR ENGLEMAN hold?
EDGAR ENGLEMAN holds: SLNO, EIGRQ, BOLT stocks.
What was EDGAR ENGLEMAN’s latest transaction?
EDGAR ENGLEMAN latest transaction was an Informative Sell of $127.84K.
What was EDGAR ENGLEMAN's most profitable transaction?
EDGAR ENGLEMAN’s most profitable transaction was an Informative Sell of BOLT stock on November 20, 2023. The return on the trade was 28.00%.
What is EDGAR ENGLEMAN's role in Soleno Therapeutics?
EDGAR ENGLEMAN's role in Soleno Therapeutics is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.